Share

PEGASUS

Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin (PEGASUS)

Project objectives

Multicenter, randomized, placebo-controlled study. Evaluation of the efficacy of ticagrelor in preventing cardiovascular events in patients with a history of prior acute myocardial infarction receiving chronic aspirin therapy.

Official website: www.timi.org

Start and end date

January 2012 - October 2014

Project Manager

Prof. Germano Di Sciascio - Principal Investigator

Coordinating institution of the project

TIMI study group

Funding source(s).

AstraZeneca

QUICK LINKS
magnifiercrossmenuchevron-downchevron-leftchevron-right